ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Jace
|
5.0K |
2.4M |
3 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Institutional Allocation
|
|
Jace
|
263 |
67K |
28 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
263
|
67K
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Jace
|
1.3K |
543K |
8 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
543K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Jace
|
1.3K |
543K |
2 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
543K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Jace
|
1.3K |
543K |
1 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
543K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Jace
|
1.3K |
543K |
20 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
543K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Jace
|
1.3K |
543K |
7 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
543K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Jace
|
3.4K |
1.1M |
11 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
11
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESO watch and banter
|
|
Jace
|
400 |
148K |
2 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
400
|
148K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Jace
|
3.4K |
1.1M |
9 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Jace
|
3.4K |
1.1M |
11 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
MSB $2 Party.
|
|
Jace
|
127 |
58K |
9 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
127
|
58K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Jace
|
5.0K |
2.4M |
28 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
5.0K
|
2.4M
|
28
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Jace
|
9.4K |
2.7M |
7 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
9.4K
|
2.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Jace
|
9.4K |
2.7M |
7 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
9.4K
|
2.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Jace
|
9.4K |
2.7M |
7 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
9.4K
|
2.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Jace
|
9.4K |
2.7M |
8 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
9.4K
|
2.7M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB $2 Party.
|
|
Jace
|
127 |
58K |
5 |
12/05/23 |
12/05/23 |
ASX - By Stock
|
127
|
58K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
Jace
|
1.1K |
319K |
5 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
1.1K
|
319K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Jace
|
9.4K |
2.7M |
8 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
9.4K
|
2.7M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Jace
|
9.4K |
2.7M |
21 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
9.4K
|
2.7M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants RMAT Designation for Rexlemestrocel-L in CLBP
|
|
Jace
|
144 |
66K |
27 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
144
|
66K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Jace
|
9.4K |
2.7M |
13 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
9.4K
|
2.7M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3G, Appendix 3H and Appendix 3Ys
|
|
Jace
|
10 |
4.8K |
3 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
10
|
4.8K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Jace
|
5.0K |
2.4M |
5 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
5.0K
|
2.4M
|
5
|
|
Charts
|
MSB |
Re:
MSB - Chart
|
|
Jace
|
248 |
103K |
9 |
14/12/22 |
14/12/22 |
Charts
|
248
|
103K
|
9
|
|
Charts
|
MSB |
Re:
MSB - Chart
|
|
Jace
|
248 |
103K |
3 |
14/12/22 |
14/12/22 |
Charts
|
248
|
103K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Calling the Bottom
|
|
Jace
|
102 |
26K |
13 |
14/12/22 |
14/12/22 |
ASX - By Stock
|
102
|
26K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
List of Spammers
|
|
Jace
|
12 |
3.7K |
26 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
12
|
3.7K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Jace
|
9.4K |
2.7M |
9 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
9.4K
|
2.7M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Jace
|
1.0K |
321K |
8 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
1.0K
|
321K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Jace
|
1.0K |
321K |
7 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
1.0K
|
321K
|
7
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron Share Price Competition Jan 1 2022
|
|
Jace
|
408 |
132K |
3 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
408
|
132K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Short Squeeze
|
|
Jace
|
505 |
160K |
23 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
505
|
160K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Jace
|
5.0K |
2.4M |
4 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
5.0K
|
2.4M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Jace
|
5.0K |
2.4M |
20 |
10/12/21 |
10/12/21 |
ASX - By Stock
|
5.0K
|
2.4M
|
20
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Chairman's Address and Presentation to AGM
|
|
Jace
|
93 |
23K |
7 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
93
|
23K
|
7
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron Share Price Competition Jan 1 2022
|
|
Jace
|
408 |
132K |
3 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
408
|
132K
|
3
|
|
ASX - By Stock
|
CGC |
Re:
Ann: Full year results announcement
|
|
Jace
|
35 |
21K |
1 |
20/10/21 |
20/10/21 |
ASX - By Stock
|
35
|
21K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Jace
|
10K |
3.0M |
3 |
20/10/21 |
20/10/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Jace
|
5.0K |
2.4M |
8 |
20/10/21 |
20/10/21 |
ASX - By Stock
|
5.0K
|
2.4M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L Improves Survival in High-Risk Acute GvHD
|
|
Jace
|
116 |
48K |
11 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
116
|
48K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L Improves Survival in High-Risk Acute GvHD
|
|
Jace
|
116 |
48K |
30 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
116
|
48K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Jace
|
5.0K |
2.4M |
5 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
5.0K
|
2.4M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Jace
|
5.0K |
2.4M |
15 |
15/10/21 |
15/10/21 |
ASX - By Stock
|
5.0K
|
2.4M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Where is Novartis?
|
|
Jace
|
1.5K |
411K |
12 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
1.5K
|
411K
|
12
|
|
ASX - By Stock
|
CGC |
Re:
Ann: Investor presentation - half year results
|
|
Jace
|
16 |
11K |
2 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
16
|
11K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Growing REAL Evidence MSB ARDS Should be Approved NOW!
|
|
Jace
|
4 |
1.7K |
1 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
4
|
1.7K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB website indicates Novartis agreement as conditions met.
|
|
Jace
|
158 |
46K |
10 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
158
|
46K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Spine Team Texas ?? MSB Filed for Approval ????
|
|
Jace
|
37 |
16K |
20 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
37
|
16K
|
20
|
|